The DOI matches its Crossref record.
Patterns of Recurrence After Initial Treatment in Patients With Small Hepatocellular Carcinoma
Abstract
To assess intrahepatic metastasis (IM) and multicentric occurrence (MO) after initial treatment of small hepatocellular carcinomas (HCC) ≤2 cm in diameter, we performed clinical and pathological studies in 112 patients who underwent percutaneous ethanol injection therapy (PEIT) or hepatic resection for HCC from January 1985 to December 1994. Patients with intrahepatic recurrences were classified into two groups based on the type of recurrence: the IM group (n = 29, 50.9%) and the MO group (n = 28, 49.1%). Overall recurrence rates after initial treatment were 23.7% at 1 year, 64.5% at 3 years, and 76.1% at 5 years. In patients with IM, the majority of intrahepatic recurrences were observed within 3 years of initial treatment and the primary HCC lesions were closely related to the degree of tumor cell differentiation. Alternatively, intrahepatic recurrences occurred throughout the follow–up period in patients with MO, and the evidence of underlying liver disease (anti–HCV [antibody to hepatitis C virus] positive) and elevated serum alfa–fetoprotein (AFP) concentrations were closely associated with intrahepatic recurrence. Prognoses following additional treatment in MO group patients were superior to those in IM group patients. These results suggest that differentiation between IM and MO in patients with HCC is important for understanding the development and biological behavior of the tumor. That is, the early detection of intrahepatic recurrence and the institution of appropriate additional therapy (PEIT or hepatic resection) may prolong survival in patients with MO.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Omata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
Omata, M., Lesmana, L. A., Tateishi, R., Chen, P.-J., Lin, S.-M., Yoshida, H., Kudo, M., Lee, J. M., Choi, B. I., Poon, R. T. P., et al. (2010) · Hepatology International · doi:10.1007/s12072-010-9165-7 · Cited by 1,026
Resection and Liver Transplantation for Hepatocellular Carcinoma
Llovet, J. M., Schwartz, M., & Mazzaferro, V. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871198 · Cited by 879
Novel advancements in the management of hepatocellular carcinoma in 2008
Llovet, J. M., & Bruix, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.022 · Cited by 815
Tung-Ping Poon, R., Fan, S.-T., & Wong, J. (2000) · Annals of Surgery · doi:10.1097/00000658-200007000-00003 · Cited by 811
Poon, R. T.-P., Fan, S.-T., Ng, I. O.-L., Lo, C.-M., Liu, C.-L., & Wong, J. (2000) · Cancer · doi:10.1002/1097-0142(20000801)89:3<500::aid-cncr4>3.0.co;2-o · Cited by 729
Roayaie, S., Blume, I. N., Thung, S. N., Guido, M., Fiel, M., Hiotis, S., Labow, D. M., Llovet, J. M., & Schwartz, M. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.003 · Cited by 660
Poon, R. T.-P., Fan, S.-T., Lo, C.-M., Liu, C.-L., & Wong, J. (1999) · Annals of Surgery · doi:10.1097/00000658-199902000-00009 · Cited by 550
Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma
Minagawa, M., Makuuchi, M., Takayama, T., & Kokudo, N. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000094549.11754.e6 · Cited by 429
Early Hepatocellular Carcinoma As An Entity With A High Rate of Surgical Cure
Takayama, T., Makuuchi, M., Hirohashi, S., Sakamoto, M., Yamamoto, J., Shimada, K., Kosuge, T., Okada, S., Takayasu, K., & Yamasaki, S. (1998) · Hepatology · doi:10.1002/hep.510280511 · Cited by 388
Significance of Resection Margin in Hepatectomy for Hepatocellular Carcinoma: A Critical Reappraisal
Poon, R. T.-P., Fan, S.-T., Ng, I. O.-L., & Wong, J. (2000) · Annals of Surgery · doi:10.1097/00000658-200004000-00014 · Cited by 357
Ercolani, G., Grazi, G. L., Ravaioli, M., Del Gaudio, M., Gardini, A., Cescon, M., Varotti, G., Cetta, F., & Cavallari, A. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000059988.22416.f2 · Cited by 352
Majno, P. E., Sarasin, F. P., Mentha, G., & Hadengue, A. (2000) · Hepatology · doi:10.1053/he.2000.5763 · Cited by 326
Zimmerman, M. A. (2008) · Archives of Surgery · doi:10.1001/archsurg.2007.39 · Cited by 278
Treatment of Hepatocellular Carcinoma
Bruix, J. (1997) · Hepatology · doi:10.1002/hep.510250201 · Cited by 277
Practice guidelines for management of hepatocellular carcinoma 2009
Korean Liver Cancer Study Group and National Cancer Center, K. (2009) · The Korean Journal of Hepatology · doi:10.3350/kjhep.2009.15.3.391 · Cited by 257
Impact of Histological Grade of Hepatocellular Carcinoma on the Outcome of Liver Transplantation
Tamura, S. (2001) · Archives of Surgery · doi:10.1001/archsurg.136.1.25 · Cited by 254
Sawada, Y., Yoshikawa, T., Ofuji, K., Yoshimura, M., Tsuchiya, N., Takahashi, M., Nobuoka, D., Gotohda, N., Takahashi, S., Kato, Y., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1129483 · Cited by 178
Self-citationEffect of vitamin K2 on the recurrence of hepatocellular carcinoma
Yoshida, H., Shiratori, Y., Kudo, M., Shiina, S., Mizuta, T., Kojiro, M., Yamamoto, K., Koike, Y., Saito, K., Koyanagi, N., et al. (2011) · Hepatology · doi:10.1002/hep.24430 · Cited by 127
Okusaka, T., Ueno, H., Ikeda, M., Mitsunaga, S., Ozaka, M., Ishii, H., Yokosuka, O., Ooka, Y., Yoshimoto, R., Yanagihara, Y., et al. (2015) · Hepatology Research · doi:10.1111/hepr.12504 · Cited by 67
Retinoids in liver fibrosis and cancer
Okuno, M. (2002) · Frontiers in Bioscience · doi:10.2741/okuno · Cited by 53
Metadata
- Authors
- Kumada, T., Nakano, S., Takeda, I., Sugiyama, K., Osada, T., Kiriyama, S., Sone, Y., Toyoda, H., Shimada, S., Takahashi, M., & Sassa, T.
- Venue
- Hepatology
- Published
- 1997-01
- Volume
- 25
- Issue
- 1
- Pages
- 87-92
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2137310322
- Cited by
- 378
- References
- 0
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.